Legal Representation
Attorney
ALICIA M. PASSERIN
USPTO Deadlines
Next Deadline
1919 days remaining
Section 8 Declaration Due (Principal Register) (Based on registration date 20250422)
Due Date
April 22, 2031
Grace Period Ends
October 22, 2031
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
46 events| Date | Code | Type | Description | Documents |
|---|---|---|---|---|
| Apr 22, 2025 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED | Loading... |
| Apr 22, 2025 | R.PR | A | REGISTERED-PRINCIPAL REGISTER | Loading... |
| Apr 1, 2025 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED | Loading... |
| Apr 1, 2025 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED | Loading... |
| Feb 27, 2025 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Feb 27, 2025 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Feb 26, 2025 | ALIE | A | ASSIGNED TO LIE | Loading... |
| Feb 18, 2025 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Nov 25, 2024 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2024 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Nov 25, 2024 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN | Loading... |
| Oct 25, 2024 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE | Loading... |
| Aug 21, 2024 | IUAF | S | USE AMENDMENT FILED | Loading... |
| Oct 25, 2024 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL | Loading... |
| Aug 21, 2024 | EISU | I | TEAS STATEMENT OF USE RECEIVED | Loading... |
| Aug 6, 2024 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT | Loading... |
| Jun 11, 2024 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | Loading... |
| Jun 11, 2024 | PUBO | A | PUBLISHED FOR OPPOSITION | Loading... |
| May 22, 2024 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | Loading... |
| May 3, 2024 | EXPT | T | EXPARTE APPEAL TERMINATED | Loading... |
| May 3, 2024 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER | Loading... |
| May 3, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| May 3, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| May 1, 2024 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED | Loading... |
| May 1, 2024 | EXPI | T | EX PARTE APPEAL-INSTITUTED | Loading... |
| May 1, 2024 | JURT | T | JURISDICTION RESTORED TO EXAMINING ATTORNEY | Loading... |
| May 1, 2024 | EXAF | T | EXPARTE APPEAL RECEIVED AT TTAB | Loading... |
| Jan 17, 2024 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jan 17, 2024 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Nov 2, 2023 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED | Loading... |
| Nov 2, 2023 | GNFR | O | FINAL REFUSAL E-MAILED | Loading... |
| Nov 2, 2023 | CNFR | R | FINAL REFUSAL WRITTEN | Loading... |
| Oct 10, 2023 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED | Loading... |
| Oct 10, 2023 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE | Loading... |
| Oct 10, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED | Loading... |
| Jul 10, 2023 | XELG | O | APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED | Loading... |
| Jul 10, 2023 | XELR | I | APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED | Loading... |
| Apr 11, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Apr 11, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED | Loading... |
| Apr 11, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 9, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED | Loading... |
| Feb 9, 2023 | GNRT | F | NON-FINAL ACTION E-MAILED | Loading... |
| Feb 9, 2023 | CNRT | R | NON-FINAL ACTION WRITTEN | Loading... |
| Feb 2, 2023 | DOCK | D | ASSIGNED TO EXAMINER | Loading... |
| Apr 20, 2022 | NWOS | I | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | Loading... |
| Apr 19, 2022 | NWAP | I | NEW APPLICATION ENTERED | Loading... |
Detailed Classifications
Class 001
Cells for scientific, medical, and diagnostic laboratory use; cell-derived preparations for scientific, medical, and diagnostic laboratory use; cells for medical and diagnostic research; cell-derived preparations for medical and diagnostic research; kits comprised of cells, reagents and instructions for using the contents of the kit for diagnostic, scientific, laboratory, and medical research; kits comprised of cell-derived preparations, reagents and instructions for using the contents of the kit for diagnostic, scientific, laboratory, and medical research; kits comprised of cells and instructions for using the contents of the kit for diagnostic, scientific, laboratory, and medical research; kits comprised of cell-derived preparations and instructions for using the contents of the kit for diagnostic, scientific, laboratory, and medical research; cells for calibration of laboratory assays, devices, and equipment; cell-derived preparations for calibration of laboratory assays, devices, and equipment; cells for use in development of laboratory assays, devices, and equipment; cell-derived preparations for use in development of laboratory assays, devices, and equipment
First Use Anywhere:
May 21, 2018
First Use in Commerce:
May 21, 2018
Class 005
Cells for clinical, medical, therapeutic and diagnostic use; cell-derived preparations for medical and diagnostic use; products comprising cells, namely, cells for medical and diagnostic use; products comprising cell-derived preparations, namely, cell-derived preparations for medical and diagnostic use; kits comprised of cells, other reagents and instructions for using the contents of the kit for medical and diagnostic use; kits comprised of cell-derived preparations and other reagents and instructions for using the contents of the kit for medical and diagnostic use; kits comprised of cells and instructions for using the contents of the kit for medical and diagnostic use; kits comprised of cell-derived preparations and instructions for using the contents of the kit for medical and diagnostic use
First Use Anywhere:
May 21, 2018
First Use in Commerce:
May 21, 2018
Class 042
Scientific, medical, and diagnostic research services, namely, research in the fields of medical products, medical devices, assay development, cell therapies, and gene therapies
First Use Anywhere:
May 6, 2024
First Use in Commerce:
May 6, 2024
Classification
International Classes
001
005
042